Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL
Abstract Measurable residual disease (MRD) is an important parameter to predict outcome in B-cell acute lymphoblastic leukemia (B-ALL). Two different approaches have been used for the assessment of MRD by multiparametric flow cytometry that include the “Leukemia Associated Aberrant Immunophenotype (LAIP)” and “Difference from Normal (DFN)” approach. In this retrospective study, we analyzed 539 samples obtained from 281 patients of which 258 were paired samples and the remaining 23 samples were from post-induction time point only, to explore the utility of baseline immunophenotype (IPT) for MRD assessment. Single-tube 10-color panel was used both at diagnosis and MRD time points. Out of 281 patients, 31.67% (n = 89) were positive and 68.32% (n = 192) were negative for MRD. Among 258 paired diagnostic and follow-up samples, baseline IPT was required in only 9.31% (24/258) cases which included cases with hematogone pattern and isolated dim to negative CD10 expression patterns. Comparison of baseline IPT with post-induction MRD positive samples showed a change in expression of at least one antigen in 94.04% cases. Although the immunophenotypic change in expression of various antigens is frequent in post-induction samples of B-ALL, it does not adversely impact the MRD assessment. In conclusion, the baseline IPT is required in less than 10% of B-ALL, specifically those with hematogone pattern and/or dim to negative expression of CD10. Hence, a combination of DFN and LAIP approach is recommended for reliable MRD assessment..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
|---|---|
| Enthalten in: |
Annals of hematology - 100(2021), 10 vom: 08. Juli, Seite 2487-2500 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Das, Nupur [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 |
|---|
| doi: |
10.1007/s00277-021-04580-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2127740289 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2127740289 | ||
| 003 | DE-627 | ||
| 005 | 20230505132808.0 | ||
| 007 | tu | ||
| 008 | 230505s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-021-04580-2 |2 doi | |
| 035 | |a (DE-627)OLC2127740289 | ||
| 035 | |a (DE-He213)s00277-021-04580-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Das, Nupur |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 | ||
| 520 | |a Abstract Measurable residual disease (MRD) is an important parameter to predict outcome in B-cell acute lymphoblastic leukemia (B-ALL). Two different approaches have been used for the assessment of MRD by multiparametric flow cytometry that include the “Leukemia Associated Aberrant Immunophenotype (LAIP)” and “Difference from Normal (DFN)” approach. In this retrospective study, we analyzed 539 samples obtained from 281 patients of which 258 were paired samples and the remaining 23 samples were from post-induction time point only, to explore the utility of baseline immunophenotype (IPT) for MRD assessment. Single-tube 10-color panel was used both at diagnosis and MRD time points. Out of 281 patients, 31.67% (n = 89) were positive and 68.32% (n = 192) were negative for MRD. Among 258 paired diagnostic and follow-up samples, baseline IPT was required in only 9.31% (24/258) cases which included cases with hematogone pattern and isolated dim to negative CD10 expression patterns. Comparison of baseline IPT with post-induction MRD positive samples showed a change in expression of at least one antigen in 94.04% cases. Although the immunophenotypic change in expression of various antigens is frequent in post-induction samples of B-ALL, it does not adversely impact the MRD assessment. In conclusion, the baseline IPT is required in less than 10% of B-ALL, specifically those with hematogone pattern and/or dim to negative expression of CD10. Hence, a combination of DFN and LAIP approach is recommended for reliable MRD assessment. | ||
| 650 | 4 | |a B-ALL | |
| 650 | 4 | |a MRD | |
| 650 | 4 | |a LAIP | |
| 650 | 4 | |a DFN | |
| 700 | 1 | |a Gupta, Ritu |0 (orcid)0000-0001-5364-4086 |4 aut | |
| 700 | 1 | |a Gupta, Sanjeev Kumar |4 aut | |
| 700 | 1 | |a Bakhshi, Sameer |4 aut | |
| 700 | 1 | |a Seth, Rachna |4 aut | |
| 700 | 1 | |a Kumar, Chandan |4 aut | |
| 700 | 1 | |a Rai, Sandeep |4 aut | |
| 700 | 1 | |a Singh, Saroj |4 aut | |
| 700 | 1 | |a Prajapati, Vijay Kumar |4 aut | |
| 700 | 1 | |a Gogia, Ajay |4 aut | |
| 700 | 1 | |a Sahoo, Ranjit Kumar |4 aut | |
| 700 | 1 | |a Sharma, Atul |4 aut | |
| 700 | 1 | |a Kumar, Lalit |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Springer Berlin Heidelberg, 1991 |g 100(2021), 10 vom: 08. Juli, Seite 2487-2500 |w (DE-627)130956759 |w (DE-600)1064950-5 |w (DE-576)025101188 |x 0939-5555 |7 nnns |
| 773 | 1 | 8 | |g volume:100 |g year:2021 |g number:10 |g day:08 |g month:07 |g pages:2487-2500 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00277-021-04580-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 100 |j 2021 |e 10 |b 08 |c 07 |h 2487-2500 | ||